Gene · 3594
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interleukin-23 receptor defines T helper 1-like regulatory T cells in oral squamous cell carcinoma. | Immun Inflamm Dis | 2022 | 36444617 | PubTator, text mining | PubMed |
| Efferocytosis drives myeloid NLRP3 dependent inflammasome signaling secretion of IL-1β to promote tumor growth. | Front Immunol | 2022 | 36439171 | PubTator, text mining | PubMed |
| Antitumor Activities of Interleukin-12 in Melanoma. | Cancers (Basel) | 2022 | 36428682 | PubTator, text mining | PubMed |
| Alzheimer's disease alters the transcriptomic profile of natural killer cells at single-cell resolution. | Front Immunol | 2022 | 36405736 | PubTator, text mining | PubMed |
| Fibrosing mediastinitis in a child with Mendelian susceptibility to mycobacterial disease possibly due to Bacillus Calmette-Guérin. | Allergy Asthma Clin Immunol | 2022 | 36397171 | PubTator, text mining | PubMed |
| Ensemble machine learning identifies genetic loci associated with future worsening of disability in people with multiple sclerosis. | Sci Rep | 2022 | 36369345 | PubTator, text mining | PubMed |
| Effectiveness and Safety of Ustekinumab for Moderate to Severely Active Crohn's Disease: Results from an Early Access Program in Brazil. | J Clin Med | 2022 | 36362709 | PubTator, text mining | PubMed |
| A novel STAT1 loss-of-function mutation associated with Mendelian susceptibility to mycobacterial disease. | Front Cell Infect Microbiol | 2022 | 36339330 | PubTator, text mining | PubMed |
| Candidate genes and sequence variants for susceptibility to mycobacterial infection identified by whole-exome sequencing. | Front Genet | 2022 | 36338958 | PubTator, text mining | PubMed |
| Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia. | J Immunother Cancer | 2022 | 36319065 | PubTator, text mining | PubMed |
| Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination. | Nat Immunol | 2022 | 36316476 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals the relationship between RCSD1 immune infiltration and clinical prognosis in human tumors. | Front Immunol | 2022 | 36311703 | PubTator, text mining | PubMed |
| Mining of transcriptome identifies CD109 and LRP12 as possible biomarkers and deregulation mechanism of T cell receptor pathway in Acute Myeloid Leukemia. | Heliyon | 2022 | 36299526 | PubTator, text mining | PubMed |
| Systems Bioinformatics Reveals Possible Relationship between COVID-19 and the Development of Neurological Diseases and Neuropsychiatric Disorders. | Viruses | 2022 | 36298824 | PubTator, text mining | PubMed |
| Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells. | Pharmaceutics | 2022 | 36297616 | PubTator, text mining | PubMed |
| Etiology of IBD-Is It Still a Mystery? | Int J Mol Sci | 2022 | 36293300 | PubTator, text mining | PubMed |
| Antibiotic Resistance to Mycobacterium tuberculosis and Potential Use of Natural and Biological Products as Alternative Anti-Mycobacterial Agents. | Antibiotics (Basel) | 2022 | 36290089 | PubTator, text mining | PubMed |
| Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma. | Biomedicines | 2022 | 36289681 | PubTator, text mining | PubMed |
| Role of Interferons in Mycobacterium tuberculosis Infection. | Clin Pract | 2022 | 36286068 | PubTator, text mining | PubMed |
| Identification of environmental factors that promote intestinal inflammation. | Nature | 2022 | 36266581 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3594/papers?page=15